These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17717263)

  • 21. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.
    Lu IC; Wu CW; Chang PY; Chen HY; Tseng KY; Randolph GW; Cheng KI; Chiang FY
    Laryngoscope; 2016 Apr; 126(4):1014-9. PubMed ID: 26748952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of profound rocuronium block monitored in three muscle groups with sugammadex in ponies.
    Mosing M; Auer U; Bardell D; Jones RS; Hunter JM
    Br J Anaesth; 2010 Oct; 105(4):480-6. PubMed ID: 20650917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected failure of rocuronium-mediated neuromuscular blockade.
    Harris P
    Anaesthesia; 2011 Jun; 66(6):525; author reply 525-6. PubMed ID: 21568992
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
    Porter MV; Paleologos MS
    Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated sugammadex usage in a patient with multiple sclerosis: a case report.
    Sinikoglu N; Totoz T; Gumus F; Karagulle O
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):71-3. PubMed ID: 25586446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.
    Bom A; Bradley M; Cameron K; Clark JK; Van Egmond J; Feilden H; MacLean EJ; Muir AW; Palin R; Rees DC; Zhang MQ
    Angew Chem Int Ed Engl; 2002 Jan; 41(2):266-70. PubMed ID: 12491405
    [No Abstract]   [Full Text] [Related]  

  • 30. The concept behind sugammadex.
    Epemolu O; Bom A
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone Does Not Inhibit Sugammadex Reversal After Rocuronium-Induced Neuromuscular Block.
    Buonanno P; Laiola A; Palumbo C; Spinelli G; Servillo G; Di Minno RM; Cafiero T; Di Iorio C
    Anesth Analg; 2016 Jun; 122(6):1826-30. PubMed ID: 27028777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios.
    Naguib M; Brewer L; LaPierre C; Kopman AF; Johnson KB
    Anesth Analg; 2016 Jul; 123(1):82-92. PubMed ID: 27140684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose sugammadex reversal: there is no such thing as a free lunch.
    Kopman AF; Brull SJ
    Anesthesiology; 2013 Jul; 119(1):10-2. PubMed ID: 23665914
    [No Abstract]   [Full Text] [Related]  

  • 34. Sugammadex: a revolutionary approach to neuromuscular antagonism.
    Kopman AF
    Anesthesiology; 2006 Apr; 104(4):631-3. PubMed ID: 16571954
    [No Abstract]   [Full Text] [Related]  

  • 35. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Extremely prolonged neuromuscular block after a single dose of rocuronium].
    Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S
    Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected failure of rocuronium-mediated neuromuscular blockade.
    Deckert D; Lederer W; Khuenl-Brady KS
    Anaesthesia; 2011 Jan; 66(1):58-9. PubMed ID: 21198505
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of sugammadex on steroid hormones: A randomized clinical study.
    Gunduz Gul G; Ozer AB; Demirel I; Aksu A; Erhan OL
    J Clin Anesth; 2016 Nov; 34():62-7. PubMed ID: 27687347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sugammadex after the reappearance of four twitches during train-of-four stimulation: monitoring and dose considerations.
    Carron M
    Anesthesiology; 2014 Feb; 120(2):508. PubMed ID: 24448082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.